Editorial: More Information on Prostate Specific Antigen and Prostate Cancer
- 1 August 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 170 (2), 457-458
- https://doi.org/10.1097/01.ju.0000077443.49060.83
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, 2002
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY:Journal of Urology, 2002
- EDITORIAL COMMENTJournal of Urology, 2001
- Preoperative Serum Prostate-specific Antigen (PSA) Below 10 μg/L Predicts Neither the Presence of Prostate Cancer Nor the Rate of Postoperative PSA FailureClinical Chemistry, 2001
- Effect of Ageing on Morphologic and Clinical Predictors of Prostate Cancer ProgressionThe Prostate Journal, 2000
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerPublished by American Medical Association (AMA) ,1994
- Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancerCancer, 1993